Clinical Trial Update: A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]

View source ↗

Summary

A completed Phase 2 multi-center study evaluating the efficacy and safety of ONO-2952 in female subjects with diarrhea-predominant irritable bowel syndrome (IBS…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome Diarrhea Predominant

Drugs mentioned

• ONO-2952

Snippet

Sponsor: Ono Pharma USA Inc | Conditions: Irritable Bowel Syndrome (IBS) | Phase 2 | Status: COMPLETED